Raffaele Strippoli

Prof. Raffaele Strippoli

Sapienza University of rome department of molecular medicine
+1
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RBRiccardo Bertini
Riccardo Bertini
MAMarcello Allegretti
Marcello Allegretti
CBCinzia Bizzarri
Cinzia Bizzarri
AMAlessio Moriconi
Alessio Moriconi
MLMassimo Locati
Massimo Locati
FCFrancesco Colotta
Francesco Colotta
The chemokine CXC ligand 8 (CXCL8)/IL-8 and related agonists recruit and activate polymorphonuclear cells by binding the CXC chemokine receptor 1 (CXCR1) and CXCR2. Here we characterize the unique mode of action of a small-molecule inhibitor (Repertaxin) of CXCR1 and CXCR2. Structural and biochemical data are consistent with a noncompetitive allosteric mode of interaction between CXCR1 and Repertaxin, which, by locking CXCR1 in an inactive conformation, prevents signaling. Repertaxin is an effective inhibitor of polymorphonuclear cell recruitmentin vivoand protects organs against reperfusion injury. Targeting the Repertaxin interaction site of CXCR1 represents a general strategy to modulate the activity of chemoattractant receptors.

5 August 2015 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
Loredana CifaldiLoredana Cifaldi
Loredana Cifaldi
GPGiusi Prencipe
Giusi Prencipe
ICIvan Caiello
Ivan Caiello
CBClaudia Bracaglia
Claudia Bracaglia
FLFranco Locatelli
Franco Locatelli
RSRaffaele Strippoli
Raffaele Strippoli
Objective: Systemic juvenile idiopathic arthritis (JIA) is associated with high levels of interleukin‐6 (IL‐6) in the serum and synovial fluid, and impairment of natural killer (NK) cell function is often observed. This study was undertaken to evaluate a possible link between these 2 biologic findings and whether they may be associated with the development of macrophage activation syndrome, a condition frequently observed in systemic JIA.Methods: Splenocytes from wild‐type (WT) or IL‐6–transgenic (Tg) mice were evaluated for NK cell cytotoxicity using a 51Cr‐release assay. Numbers of NK cells and expression of perforin, granzyme B, CD69, and CD107a were evaluated by flow cytometry. Human peripheral blood mononuclear cells (PBMCs) isolated from healthy donors were treated with IL‐6 and cultured in the presence or absence of tocilizumab (TCZ), an IL‐6 receptor blocker. Human polyclonal NK cells from healthy donor PBMCs were evaluated for cell cytotoxicity and expression of perforin, granzyme B, and CD107a. PBMCs harvested from patients with systemic JIA during periods of active or inactive disease were left untreated or treated with IL‐6 in combination with soluble IL‐6 receptor and analyzed for the expression of perforin and granzyme B.Results: Splenic NK cell cytotoxicity was reduced in IL‐6–Tg mice compared to WT mice. Levels of CD69 and CD107a showed no significant differences, whereas expression of perforin and granzyme B was impaired in NK cells from IL‐6–Tg mice. Exposure of human peripheral blood NK cells to IL‐6 led to reduced expression of perforin and granzyme B. Culturing human polyclonal NK cells in the presence of TCZ significantly increased cell cytotoxicity, and also increased expression of perforin and granzyme B. In patients with systemic JIA, a reduction in IL‐6 plasma levels during disease remission correlated with the rescue of perforin and granzyme B expression in NK cells from these patients.Conclusion: In both mice and humans, IL‐6 down‐modulated the cytotoxic activity of NK cells. This decrease was associated with reduced perforin and granzyme B levels in the absence of altered granule exocytosis.

31 January 2016 in Stem Cells International
Verified
Journal Article
Open access
PDF file
RSRaffaele Strippoli
Raffaele Strippoli
RMRoberto Moreno-Vicente
Roberto Moreno-Vicente
Cecilia BattistelliCecilia Battistelli
Cecilia Battistelli
CCCarla Cicchini
Carla Cicchini
VNValeria Noce
Valeria Noce
MTMarco Tripodi
Marco Tripodi
Peritoneal dialysis is a form of renal replacement alternative to the hemodialysis. During this treatment, the peritoneal membrane acts as a permeable barrier for exchange of solutes and water. Continual exposure to dialysis solutions, as well as episodes of peritonitis and hemoperitoneum, can cause acute/chronic inflammation and injury to the peritoneal membrane, which undergoes progressive fibrosis, angiogenesis, and vasculopathy, eventually leading to discontinuation of the peritoneal dialysis. Among the different events controlling this pathological process, epithelial to mesenchymal transition of mesothelial cells plays a main role in the induction of fibrosis and in subsequent functional deterioration of the peritoneal membrane. Here, the main extracellular inducers and cellular players are described. Moreover, signaling pathways acting during this process are elucidated, with emphasis on signals delivered by TGF‐β family members and by Toll‐like/IL‐1β receptors. The understanding of molecular mechanisms underlying fibrosis of the peritoneal membrane has both a basic and a translational relevance, since it may be useful for setup of therapies aimed at counteracting the deterioration as well as restoring the homeostasis of the peritoneal membrane.

1 November 2018 in Cell Reports
Verified
Journal Article
Open access
RMRoberto Moreno-Vicente
Roberto Moreno-Vicente
DPDácil María Pavón
Dácil María Pavón
IMInés Martín-Padura
Inés Martín-Padura
MCMauro Català-Montoro
Mauro Català-Montoro
ADAlberto Díez-Sánchez
Alberto Díez-Sánchez
MPMiguel A. del Pozo
Miguel A. del Pozo
The transcriptional regulator YAP orchestrates many cellular functions, including tissue homeostasis, organ growth control, and tumorigenesis. Mechanical stimuli are a key input to YAP activity, but the mechanisms controlling this regulation remain largely uncharacterized. We show that CAV1 positively modulates the YAP mechanoresponse to substrate stiffness through actin-cytoskeleton-dependent and Hippo-kinase-independent mechanisms. RHO activity is necessary, but not sufficient, for CAV1-dependent mechanoregulation of YAP activity. Systematic quantitative interactomic studies and image-based small interfering RNA (siRNA) screens provide evidence that this actin-dependent regulation is determined by YAP interaction with the 14-3-3 protein YWHAH. Constitutive YAP activation rescued phenotypes associated with CAV1 loss, including defective extracellular matrix (ECM) remodeling. CAV1-mediated control of YAP activity was validated in vivo in a model of pancreatitis-driven acinar-to-ductal metaplasia. We propose that this CAV1-YAP mechanotransduction system controls a significant share of cell programs linked to these two pivotal regulators, with potentially broad physiological and pathological implications.

29 March 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
MTMichela Terri
Michela Terri
FTFlavia Trionfetti
Flavia Trionfetti
CMClaudia Montaldo
Claudia Montaldo
Marco CordaniMarco Cordani
Marco Cordani
MTMarco Tripodi
Marco Tripodi
RSRaffaele Strippoli
Raffaele Strippoli
Peritoneal fibrosis is characterized by abnormal production of extracellular matrix proteins leading to progressive thickening of the submesothelial compact zone of the peritoneal membrane. This process may be caused by a number of insults including pathological conditions linked to clinical practice, such as peritoneal dialysis, abdominal surgery, hemoperitoneum, and infectious peritonitis. All these events may cause acute/chronic inflammation and injury to the peritoneal membrane, which undergoes progressive fibrosis, angiogenesis, and vasculopathy. Among the cellular processes implicated in these peritoneal alterations is the generation of myofibroblasts from mesothelial cells and other cellular sources that are central in the induction of fibrosis and in the subsequent functional deterioration of the peritoneal membrane. Myofibroblast generation and activity is actually integrated in a complex network of extracellular signals generated by the various cellular types, including leukocytes, stably residing or recirculating along the peritoneal membrane. Here, the main extracellular factors and the cellular players are described with emphasis on the cross-talk between immune system and cells of the peritoneal stroma. The understanding of cellular and molecular mechanisms underlying fibrosis of the peritoneal membrane has both a basic and a translational relevance, since it may be useful for setup of therapies aimed at counteracting the deterioration as well as restoring the homeostasis of the peritoneal membrane.

1 April 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
GPGiusi Prencipe
Giusi Prencipe
ICIvan Caiello
Ivan Caiello
APAntonia Pascarella
Antonia Pascarella
AGAlexei A. Grom
Alexei A. Grom
CBClaudia Bracaglia
Claudia Bracaglia
FBFabrizio De Benedetti
Fabrizio De Benedetti